Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1347-1352
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, J.
Right arrow Articles by Stampfer, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, J.
Right arrow Articles by Stampfer, M. J.

A prospective study of fibrinogen and risk of myocardial infarction in the physicians’ health study

Jing Ma, MD, PhD*, Charles H. Hennekens, MD, DrPH* {dagger} §, Paul M. Ridker, MD{dagger} {ddagger} and Meir J. Stampfer, MD, DrPH* § ||

* Channing Laboratory, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
{dagger} Division of Preventive Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
{ddagger} Division of Cardiovascular Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
§ Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
|| Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA



View larger version (14K):

[in a new window]
 
Figure 1 Age- and smoking-adjusted relative risk (95% confidence interval) of future myocardial infarction associated with baseline plasma fibrinogen levels in the Physicians’ Health Study. Numbers of cases/control subjects were: 89/99 in the 1st to 50th percentile, 73/80 in the 51st to 90th percentile and 37/20 in the >90th percentile.

 


View larger version (13K):

[in a new window]
 
Figure 2 Age- and smoking-adjusted relative risk (95% confidence interval) of future myocardial infarction according to fibrinogen levels and aspirin assignment in the Physicians’ Health Study. Numbers of cases/control subjects were: in aspirin group, 50/80 for fibrinogen <343 mg/dl, 15/10 for fibrinogen ≥343 mg/dl; in placebo group, 112/99 for fibrinogen <343 mg/dl, 22/10 for fibrinogen ≥343 mg/dl.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement